Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7192903 | 0.83 | CHRM1 (0.35) | ALDH1A1TSHRCHRM1AKR1A1CHRM3 | |
| SCHEMBL28035109 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHRCA1CA2HDAC7 | |
| SCHEMBL15945448 | 0.79 | CA1 (0.42) | ALDH1A1TSHRTRPV1CA1CA2 | |
| SCHEMBL28046131 | 0.77 | TSHR (0.34) | ALDH1A1TSHRTRPV1CHRM1AKR1A1 | |
| SCHEMBL7126340 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHRTRPV1HDAC7HDAC8 | |
| SCHEMBL2465319 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHRTRPV1HDAC7HDAC8 | |
| SCHEMBL17323727 | 0.76 | TSHR (0.40) | ALDH1A1TSHRTRPV1HDAC7HDAC8 | |
| SCHEMBL23779944 | 0.74 | CHRM1 (0.46) | TSHRCA2CHRM1AKR1A1CHRM3 | |
| SCHEMBL5859582 | 0.74 | CHRM1 (0.46) | TSHRCA2CHRM1AKR1A1CHRM3 | |
| SCHEMBL27847759 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRCHRM1AKR1A1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118930602-A | Method for performing terminal allylation modification on natural amino acid or polypeptide | 南京工业大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-115806488-A | Method for ring-opening allylation of cycloalkanol | 南京工业大学 | 2023-03-17 | — | — | CN | disclosed |
| US-20090131707-A1 | CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS | NOVARTIS AG (CH) | 2009-05-21 | — | — | US | disclosed |
| US-7452999-B2 | Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compounds | NOVARTIS AG (CH) | 2008-11-18 | — | — | US | disclosed |
| US-20070179298-A1 | Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds | NOVARTIS AG (CH) | 2007-08-02 | — | — | US | disclosed |
| EP-1599440-A2 | CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS | Novartis AG (CH) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004076053-A2 | CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS | NOVARTIS AG (CH) | 2004-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131707-A1 | CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS | HAO2, HAO1, HAAO | ALDH1A1 575/4885TSHR 4081/4885TRPV1 4460/4885 |
| US-20070179298-A1 | Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds | HAO1, LMNA, HAO2 | ALDH1A1 765/4885TSHR 4123/4885TRPV1 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.